Khanu Management GmbH

https://www.khan-1.de

September 2019 Khanu announces the successful launch of KHAN Technology Transfer Fund I, based in Dortmund, Germany The European Investment Fund, the Austria Wirtschaftsservice and the Max Planck Foundation committed in a first closing an investment of a total volume of € 60 million into KHAN-I for a period of 5 plus 2 years in early-stage drug discovery projects. The Khanu fund management team will invest a minority amount.The EIF will provide up to € 30 million through “InnovFin Equity Facility for Early Stage”, an integral part of the European growth initiative. The investment is supported by the Juncker Plan’s European Fund for Strategic Investments. Projects are sourced predominantly from academia in Germany and Austria, focussing on innovative therapeutic opportunities in indications with high unmet medical need. KHAN-I will invest into either innovative project ideas covered by collaboration agreements or into start-up vehicles. The Lead Discovery Center in Dortmund a professional drug discovery and translational research incubator originally founded by Max-Planck-Innovation GmbH with a proven track record will provide its drug discovery services to incubate these novel project hypotheses, where applicable. To facilitate professional translation in life sciences in Austria, KHAN-I has founded Vienna-based wings4innovation GmbH for scouting and executing promising drug discovery projects on behalf of KHAN-I and Khanu. The Partnership is supported by aws with funds provided by the Austrian Federal Ministry for Digital and Economic Affairs and the Austrian Foundation for Research, Technology and Development. KHAN-I also signed a co-investment agreement with the Max Planck Gesellschaft, Germany´s largest basic research organisation, adding € 18 million of co-funding for drug discovery projects originating from the world class biomedical research of the Max Planck Institutes. *

	Start	established
	Group	Khanu Management (Group)
	Industry	venture capital
	Industry 2	drug discovery
	Person	Klebl, Bert (Lead Discovery Center 200806– CEO)
	Person 2	Nussbaumer, Peter (Max Planck 201104 Managing Director of Lead Discovery Center GmbH)

	Region	Dortmund
	Country	Germany
	Street	15 Otto-Hahn-Str.
	City	44227 Dortmund
		Address record changed: 2021-04-23

Basic data	Employees	n. a.

		* Document for »About Section«: Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I".

		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Khanu Management (Group)

[1] Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)